KRAS and non-small cell lung carcinoma: We previously found that elevated PM2.5 levels were linked to increased risk of TP53 somatic mutations (Erhunmwunsee et al. 2021), which, like KRAS somatic mutations, are associated with worse NSCLC mortality.